Legence Corp. (LGN) names ex-CFO Robert Crisci to board
Rhea-AI Filing Summary
Legence Corp. (LGN) expanded its Board of Directors from six to seven members and appointed Robert Crisci, age 51, as a Class II director effective August 18, 2026. His initial term runs until the 2027 annual meeting of shareholders or earlier termination events.
Crisci was appointed to the Board’s Audit Committee and Nomination and Corporate Governance Committee. He has extensive public company experience, including serving as Chief Financial Officer of Lineage, Inc. from 2023 to November 2025 and previously of Roper Technologies, Inc. from 2017 to January 2023. The Board determined he meets Nasdaq, SEC and company independence standards.
As a non-management director, Crisci will receive standard compensation: an annual $85,000 cash retainer and restricted stock units in Class A common stock valued at approximately $150,000 as of the grant date. He also entered into the company’s standard form of indemnification agreement.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Board size after change: 7 directors
Director age: 51 years
Annual cash retainer: $85,000 per year
+2 more
5 metrics
Board size after change
7 directors
Board increased from six to seven directors effective August 18, 2026
Director age
51 years
Age of newly appointed director Robert Crisci
Annual cash retainer
$85,000 per year
Standard annual cash compensation for non-management directors including Robert Crisci
RSU grant value
$150,000
Approximate grant-date value of restricted stock units for non-management directors
Class term end
2027
Initial term of Class II directorship expires at 2027 annual meeting
Key Terms
Class II director, restricted stock units, indemnity agreement, Emerging growth company, +1 more
5 terms
Class II director regulatory
"appointed Mr. Robert Crisci to the Board as a Class II director"
A class II director is a member of a company’s board who belongs to one of several staggered groups of directors, each group standing for election in different years. For investors, this matters because staggered terms slow wholesale board turnover—like rotating members of a neighborhood committee—making sudden changes in control or strategy harder and affecting how quickly shareholders can influence corporate direction.
restricted stock units financial
"an award of restricted stock units covering a certain number of shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
indemnity agreement regulatory
"He has also entered into the Company’s standard form of indemnity agreement"
Emerging growth company regulatory
"Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2... Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
independent medical examinations medical
"ExamWorks, LLC, a leading provider of independent medical examinations, peer reviews"
FAQ
What Board change did Legence Corp. (LGN) announce on August 18, 2026?
Legence Corp. increased its Board size from six to seven directors and appointed Robert Crisci as a Class II director, effective August 18, 2026. His initial term runs until the company’s 2027 annual meeting of shareholders.
Who is Robert Crisci, the new director appointed by Legence Corp. (LGN)?
Robert Crisci is a 51-year-old executive with extensive CFO experience at large public companies, including Lineage, Inc. and Roper Technologies, Inc. He has a background in financial reporting, audit, internal controls, financial analysis, investor relations and M&A.
Which Board committees will Robert Crisci serve on at Legence Corp. (LGN)?
Robert Crisci was appointed to the Audit Committee and the Nomination and Corporate Governance Committee. These assignments align with his financial, audit and governance background, supporting oversight of financial reporting and board composition matters.
What compensation will Robert Crisci receive as a Legence Corp. (LGN) director?
Crisci will receive standard non-management director pay: a $85,000 annual cash retainer plus restricted stock units in Class A common stock valued at approximately $150,000 on the grant date, along with the company’s standard indemnification protections.
Is Robert Crisci considered an independent director of Legence Corp. (LGN)?
Yes. The Board determined that Robert Crisci meets independence requirements under Nasdaq rules, applicable SEC regulations and Legence Corp.’s internal guidelines for director independence, following a review of relevant facts and circumstances.
How long will Robert Crisci serve on the Board of Legence Corp. (LGN)?
As a Class II director, Robert Crisci’s initial term will expire at the 2027 annual meeting of shareholders, or earlier if he dies, resigns, retires or is removed in accordance with applicable corporate governance provisions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
